| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 |
| Total Revenue |
-
|
-
|
-
|
-
|
| Cost of Revenue |
-
|
-
|
-
|
-
|
|
| Gross Profit |
-
|
-
|
-
|
-
|
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
-
|
| Selling General and Administrative | 223 | 120 | 124 | 358 |
| Non Recurring | 110 | (110) |
-
|
-
|
| Others | 3 | 3 | 23 | 78 |
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (226) | (12) | (147) | (436) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 110 |
-
|
-
|
-
|
| Earnings Before Interest And Taxes | (226) | (12) | (147) | (436) |
| Interest Expense |
-
|
-
|
-
|
-
|
| Income Before Tax | (226) | (12) | (147) | (436) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (226) | (12) | (147) | (436) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | (226) | (12) | (147) | (436) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($226) | ($12) | ($147) | ($436) |
0.51% Nasdaq 
Income Statement
